Global Microcarrier Market Size 2024, Forecast To 2033
22 Feb, 2024
The microcarrier market has grown rapidly, reaching $2 billion in 2023 and projecting to $2.2 billion in 2024, with a 10.1% CAGR. Growing demand for cell-based vaccines and increased R&D activities fueled historic growth. The forecast predicts growth to $3.36 billion by 2028, driven by cancer cases and regenerative medicine demand. Trends include scalable microcarriers and advanced material integration.
Global Microcarrier Market Key Driver
The microcarrier market is witnessing growth with the increase in the prevalence of cancer cases. As the number of cancer cases increases globally, microcarriers support the proliferation of cancer cells and the formation of microtissue for repair and restoration, contributing to the market's growth.
Get A Free Sample Of The Global Microcarrier Market ReportGlobal Microcarrier Market Segments
The microcarrier market covered in this report is segmented –
1)By Product: Equipment, Consumables
2)By Type: Cationic Microcarriers, Collagen-Coated Microcarriers, Protein-Cated Microcarriers, Untreated Microcarriers, Other Microcarriers
3)By Material Type: Alginate-Based, Collagen-Based, Dextran-Based, Polystyrene-Based, Other Material Type
4)By Application: Vaccine Manufacturing, Cell Therapy, Other Applications
5)By End User: Pharmaceutical And Biotechnology Companies, Research Institutes, CROs
By Geography: The regions covered in the template market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North America was the largest region in the microcarrier market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microcarrier market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Microcarrier Industry Players
Thermo Fisher Scientific Inc.; The Merck Group; GE Healthcare Technologies Inc.; Corning Incorporated; Lonza Group AG; Microcarrier Global; Sartorius AG; Getinge AB; ChemoMetec; Cesco Bioengineering Co. Ltd.; Himedia Laboratories Pvt. LTtd.; Esco VacciXcell; Danaher Corporation; Eppendorf AG; Solida Biotech GmbH; CellGenix GmbH; FUJIFILM Irvine Scientific Inc.; Stemcell Technologies Inc.; Bio-Techne Corporation; InVitria Inc.; CytoSMART Technologies BV; Synthace Limited; Cell Guidance Systems Ltd.; BioLamina AB; Cell Culture Company LLC; Cell Applications Inc.; CellSystems Biotechnologie Vertrieb GmbH; Cellon SA; Repligen corporation; VWR International
Get The Full Global Microcarrier Market Report
Microcarrier Market Overview
Microcarrier refers to a support array that enables adherent cells to increase in bioreactors. Microcarriers focus on providing anchorage or a connection surface for suspended cell cultures, which aids in cell viability. It aids in increasing cell numbers and maintaining the proper phenotype for tissue repair and its function restoration.
Microcarrier Global Market Report 2023 provides data on the global microcarrier market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The microcarrier market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.